CN106798750B - 一种复方奥美拉唑干混悬剂的制备方法 - Google Patents
一种复方奥美拉唑干混悬剂的制备方法 Download PDFInfo
- Publication number
- CN106798750B CN106798750B CN201710178289.XA CN201710178289A CN106798750B CN 106798750 B CN106798750 B CN 106798750B CN 201710178289 A CN201710178289 A CN 201710178289A CN 106798750 B CN106798750 B CN 106798750B
- Authority
- CN
- China
- Prior art keywords
- omeprazole
- sucrose
- meshes
- compound
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Botany (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
编号 | 活性成分 | mg/包 | 质量百分比/% |
1 | 奥美拉唑 | 20mg | 0.33 |
2 | 碳酸氢钠 | 1680mg | 27.9 |
3 | 蔗糖 | 3600mg | 59.8 |
4 | 木糖醇 | 600mg | 9.97 |
5 | 三氯蔗糖 | 100mg | 1.66 |
6 | 黄原胶 | 10mg | 0.16 |
7 | 菠萝粉末香精 | 10mg | 0.16 |
编号 | 活性成分 | mg/包 | 质量百分比/% |
1 | 奥美拉唑 | 40mg | 0.66 |
2 | 碳酸氢钠 | 1680mg | 27.8 |
3 | 蔗糖 | 3600mg | 59.6 |
4 | 木糖醇 | 600mg | 9.93 |
5 | 三氯蔗糖 | 100mg | 1.65 |
6 | 黄原胶 | 10mg | 0.16 |
7 | 菠萝粉末香精 | 10mg | 0.16 |
组别 | 项目 | 最大杂质 | 溶出度(30min)/% | 耐酸力pH | 耐酸力(30min)/% |
样品1 | 20mg本品 | 0.053 | 98.19% | 7.85 | 99.44 |
样品2 | 40mg本品 | 0.045 | 97.54% | 7.90 | 99.70 |
样品3 | 20mg对比 | 0.08 | 93.7 | 7.38 | 93.7 |
样品4 | 40mg对比 | 0.055 | 92.13 | 3.97 | 92.13 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710178289.XA CN106798750B (zh) | 2017-03-23 | 2017-03-23 | 一种复方奥美拉唑干混悬剂的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710178289.XA CN106798750B (zh) | 2017-03-23 | 2017-03-23 | 一种复方奥美拉唑干混悬剂的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106798750A CN106798750A (zh) | 2017-06-06 |
CN106798750B true CN106798750B (zh) | 2019-08-20 |
Family
ID=58988457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710178289.XA Active CN106798750B (zh) | 2017-03-23 | 2017-03-23 | 一种复方奥美拉唑干混悬剂的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106798750B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111388425B (zh) * | 2020-04-22 | 2020-12-08 | 一力制药(罗定)有限公司 | 一种奥美拉唑干混悬剂及其制备方法 |
CN111665337B (zh) * | 2020-06-30 | 2021-08-03 | 北京诺康达医药科技股份有限公司 | 一种肠溶片耐酸力的快速检测方法 |
CN115487151B (zh) * | 2022-09-19 | 2023-04-07 | 杭州沐源生物医药科技有限公司 | 一种复方奥美拉唑干混悬剂及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1935139A (zh) * | 2006-09-30 | 2007-03-28 | 邢为藩 | 一种取代苯并咪唑质子泵抑制剂组合物及其制备方法 |
CN101991543A (zh) * | 2009-08-10 | 2011-03-30 | 杭州赛利药物研究所有限公司 | 一种奥美拉唑肠溶干混悬剂及其制备方法 |
CN102641286A (zh) * | 2012-03-12 | 2012-08-22 | 南京海纳医药科技有限公司 | 复方奥美拉唑干混悬剂及其制备方法 |
CN103054896A (zh) * | 2012-12-29 | 2013-04-24 | 北京阜康仁生物制药科技有限公司 | 一种包含奥美拉唑和碳酸氢钠的复方干混悬制剂 |
-
2017
- 2017-03-23 CN CN201710178289.XA patent/CN106798750B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1935139A (zh) * | 2006-09-30 | 2007-03-28 | 邢为藩 | 一种取代苯并咪唑质子泵抑制剂组合物及其制备方法 |
CN101991543A (zh) * | 2009-08-10 | 2011-03-30 | 杭州赛利药物研究所有限公司 | 一种奥美拉唑肠溶干混悬剂及其制备方法 |
CN102641286A (zh) * | 2012-03-12 | 2012-08-22 | 南京海纳医药科技有限公司 | 复方奥美拉唑干混悬剂及其制备方法 |
CN103054896A (zh) * | 2012-12-29 | 2013-04-24 | 北京阜康仁生物制药科技有限公司 | 一种包含奥美拉唑和碳酸氢钠的复方干混悬制剂 |
Also Published As
Publication number | Publication date |
---|---|
CN106798750A (zh) | 2017-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106798750B (zh) | 一种复方奥美拉唑干混悬剂的制备方法 | |
CN101766648B (zh) | 聚乙二醇电解质颗粒制剂及其制造方法 | |
CN102861106B (zh) | 一种复方氨酚烷胺微丸的制备方法 | |
CN101389323B (zh) | 含有磷酸奥塞米韦的药物组合物 | |
CN103860584B (zh) | 一种奥美拉唑碳酸氢钠胶囊的制作方法 | |
CN103251648B (zh) | 治疗血磷酸盐过多症及缺铁性贫血症的铁基蒙脱石药物及其制备方法 | |
CN102133225B (zh) | 一种复方聚乙二醇电解质散剂及其制备方法 | |
CN108635332A (zh) | 一种伏格列波糖颗粒的制备方法 | |
CN103360386B (zh) | 一种盐酸托烷司琼化合物及其制备方法及含有该化合物的药物组合物 | |
CN112516083A (zh) | 布洛芬混悬液及其制备方法 | |
CN106176653A (zh) | 一种西格列汀的药物组合物 | |
CN112791054B (zh) | 一种干混悬剂的干法制粒法 | |
CN103880906B (zh) | 一种丁酸氢化可的松半水合物 | |
CN105232503B (zh) | 一种盐酸达泊西汀片 | |
CN207506783U (zh) | 一种复方奥美拉唑干混悬剂湿法制备装置 | |
CN109908104B (zh) | 一种阿莫西林胶囊及其制备方法 | |
CN116869939A (zh) | 一种磷酸奥司他韦脂质体、制备方法及制剂 | |
CN107468661A (zh) | 一种含有非布司他的药物组合物 | |
CN103230387B (zh) | 一种肠溶型复合酸化剂微丸及其制备方法 | |
CN102311383B (zh) | 盐酸非那吡啶的晶体化合物及其药物组合物片剂 | |
CN105078932A (zh) | 一种提高药物制剂中细粒子比例的方法及其制剂 | |
CN116831997B (zh) | 一种呈片状形式的固体药物组合物及其制备方法 | |
CN101002767A (zh) | 青霉素v钾分散片及其制备方法 | |
CN100500128C (zh) | 一种活性炭口服混悬液、制备方法及其应用 | |
CN104721164B (zh) | 一种盐酸西那卡塞薄膜衣片组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A preparation method of compound omeprazole dry suspension Effective date of registration: 20210723 Granted publication date: 20190820 Pledgee: China Postal Savings Bank Co.,Ltd. Jining Branch Pledgor: JINING HUANENG PHARMACEUTICAL FACTORY Co.,Ltd. Registration number: Y2021980006672 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230103 Granted publication date: 20190820 Pledgee: China Postal Savings Bank Co.,Ltd. Jining Branch Pledgor: JINING HUANENG PHARMACEUTICAL FACTORY CO.,LTD. Registration number: Y2021980006672 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A preparation method of compound omeprazole dry suspension Effective date of registration: 20230221 Granted publication date: 20190820 Pledgee: China Postal Savings Bank Co.,Ltd. Jining Branch Pledgor: JINING HUANENG PHARMACEUTICAL FACTORY CO.,LTD. Registration number: Y2023980033097 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |